Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Concord Biotech Ltd

NSE: CONCORDBIO

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Concord Biotech Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 12,860.47 Cr.
Price in snapshot: ₹ 1,229.3
ROE: 13.53 %
ROCE: 15.34 %
Dividend Yield: 0.61 %

Snapshot updated 22 July 2026. Figures are not live quotes.

Research coverage

Concall documents: presentation for Q2 FY27, dated 27 October 2026.
Annual-report coverage: FY2026.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings